- Tofacitinib Impurity N
-
- $0.00 / 10mg
-
2025-03-04
- CAS:1640972-35-5
- Min. Order: 10mg
- Purity: 0.98
- Supply Ability: 10g
- Tofacitinib Impurity 6
-
- $6.60 / 1KG
-
2019-12-26
- CAS:1640972-35-5
- Min. Order: 500g
- Purity: 98%
- Supply Ability: 1KG, 50KG, 100KG
|
| | Tofacitinib Impurity 6 Basic information |
| Product Name: | Tofacitinib Impurity 6 | | Synonyms: | Tofacitinib Impurity 39;N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-2-amine;Tofacitinib-21;Tofacitinib impurity 14/5,6-Dihydro Tofacitinib/3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile;Tofacitinib impurity 15/5,6-Dihydro Tofacitinib Citrate/3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate;5,6-Dihydro CP-690550;3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile;Tofacitinib Related Compound 21 | | CAS: | 1640972-35-5 | | MF: | C16H22N6O | | MW: | 314.39 | | EINECS: | | | Product Categories: | | | Mol File: | 1640972-35-5.mol |  |
| | Tofacitinib Impurity 6 Chemical Properties |
| Melting point | >80°C (dec.) | | Boiling point | 583.2±50.0 °C(Predicted) | | density | 1.239±0.06 g/cm3(Predicted) | | storage temp. | -20°C Freezer | | solubility | DMSO (Slightly), Methanol (Slightly) | | pka | 6.04±0.60(Predicted) | | form | Solid | | color | Pale Yellow to Yellow |
| | Tofacitinib Impurity 6 Usage And Synthesis |
| Uses | 5,6-Dihydro CP-690550 is an impurity of CP-690550 (C781350), a pyrrolo[2,3-d]pyrimidine derivative, as Janus kinase inhibitor for treatment of rheumatoid arthritis. |
| | Tofacitinib Impurity 6 Preparation Products And Raw materials |
|